Effect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients

To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a multiple-dose, three-period, placebo-controlled, crossover study. Patients were randomly assigned to receive...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	De Wit, S., Debier, M., De Smet, M., McCrea, J., Stone, J., Carides, A., Matthews, C., Deutsch, P., Clumeck, N.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1998
Soggetti:	Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105391/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9527763/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.2.223
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!